You have the power to end brain cancer.
Prostate cancer is the most common cancer among Canadian men (excluding non-melanoma skin cancers). It is the 3rd leading cause of death from cancer in men in Canada.
To provide the most current cancer statistics, researchers use statistical methods to estimate the number of new cancer cases and deaths until actual data become available.
Incidence is the total number of new cases of cancer. Mortality is the number of deaths due to cancer.
It is estimated that in 2015:
Incidence rate (for every 100,000 people)*
Death rate (for every 100,000 people)*
5-year relative survival (estimates for 2006–2008)
*Age-standardized to the 1991 Canadian Standard Population. Age-standardization is a statistical method that removes the effect of age on the calculated rate. It allows rates to be compared over time or across provinces and territories.
In Canada, the incidence rate of prostate cancer peaked in 1993 and 2001. Each of these peaks was followed by a decline. These peaks are compatible with two waves of intensified PSA testing. Since 2001, the incidence rate has generally been declining
The mortality rate for prostate cancer rose slowly from 1986 to the mid-1990s, when it began to decline. Since 2006, the decline in mortality rate for prostate cancer has slowed.
Based on 2010 estimates, about 1 in 8 Canadian men is expected to develop prostate cancer during his lifetime and 1 in 27 will die from it.
For more information, go to Canadian Cancer Statistics publication.
The Canadian Cancer Society is actively lobbying the federal government to establish a national caregivers strategy to ensure there is more financial support for this important group of people.